Infection control is a core part of patient care in Cystic Fibrosis (CF). In this time of the COVID-19 pandemic, much of the world is now dealing with many of the infection control issues that our CF patients and families deal with on a daily basis. In many ways, our patients and families are better prepared than most, and the adaptation has been less abrupt. Moreover, our COVID-19 experiences are somewhat re-enforcing our CF infection control approaches. We now have a pro-con debate about how to achieve the goals of protection without unduly encumbering our patients and families, CF teams, and healthcare facilities. You will see that there is much commonality between the two, and I very much appreciate the careful literature review and opinions provided [1,2]. You, the reader, will need to see what works best for you and your clinic. Here, I will share some personal reflections that I hope will give yet another way for you to compare. I must point out that my hospital is in a city with one of the world’s highest rates of COVID19 infection, yet children are rarely symptomatic.